Skip to main content
TIL logo
TIL
(NASDAQ)
Instil Bio, Inc.
$7.43-- (--)
Loading... - Market loading

Instil Bio (TIL) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Instil Bio, Inc.
TILNasdaq Stock MarketHealthcareBiotechnology

About Instil Bio

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

Company Information

CEOBronson Crouch
Founded2018
IPO DateMarch 19, 2021
Employees17
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone972 499 3350
Address
3963 Maple Avenue, Suite 350 Dallas, Texas 75219 United States

Corporate Identifiers

CIK0001789769
CUSIP45783C101
ISINUS45783C2008
EIN83-2072195
SIC2836

Leadership Team & Key Executives

Bronson Crouch
Chairman and Chief Executive Officer
Dr. Sandeep Laumas M.D.
Chief Financial Officer and Chief Business Officer